Prof. Dr. Taner BAŞTÜRK

1. Burden and correlates of anemia in IgA nephropathy versus other primary glomerulonephritides

Naghizade K., Uk E., Aydin M. F., Ozler T. E., EREN N., Ozcan S. G., et al.

BMC Nephrology , cilt.27, sa.1, 2026 (SCI-Expanded, Scopus)

2. Histopathological predictors of renal outcomes in idiopathic membranous nephropathy with a focus on global sclerotic glomeruli ratio

Tunca O., Turkmen A., EREN N., Yadigar S., Karagoz F., DİNÇER M. T., et al.

Scientific Reports , cilt.16, sa.1, 2026 (SCI-Expanded, Scopus)

3. Prognostic value of the ratio of globally sclerotic glomeruli in patients with idiopathic IgA nephropathy

Kazan S., Öztürk S., Uzerk Kibar M., Ozcan S. G., Alcelik Karacan R. D., EREN N., et al.

Scientific Reports , cilt.16, sa.1, 2026 (SCI-Expanded, Scopus)

4. Sex Differences in Baseline Characteristics and Long-Term Outcomes of Primary Glomerular Diseases: Insights from the TSN-GOLD Registry

Guven Taymez D., Uk E., EREN N., Kıykım A. A., DİNÇER M. T., Pınar M., et al.

Journal of Clinical Medicine , cilt.15, sa.11, 2026 (SCI-Expanded, Scopus)

5. Post-COVID-19 Outcomes of Patients with Autosomal Dominant Polycystic Kidney Disease: A Multicenter Controlled Study

KARADAĞ S., Ozturk S., Aktas N., TRABULUS S., AYDIN Z., Dheir H., et al.

Journal of Clinical Medicine , cilt.15, sa.5, 2026 (SCI-Expanded, Scopus)

6. The Optimal Management Strategy for IGA Nephropathy Patients With Different Clinical Presentations

Ozturk S., Sumnu A., EREN N., DİNÇER M. T., UZUN S., Suleymanova V., et al.

Nephrology , cilt.31, sa.3, 2026 (SCI-Expanded, Scopus)

7. Prognostic Implications of Serum C3 Levels in Primary Membranous Nephropathy: A Retrospective Cohort Analysis Implicaciones Pronósticas de los Niveles Séricos de C3 en la Nefropatía Membranosa Primaria: Un Análisis de Cohorte Retrospectivo

Onan E., UÇAR A. S., ORUÇ A., Doksan M., EREN N., KARADAĞ S., et al.

Revista de Nefrologia, Dialisis y Trasplante , cilt.46, sa.1, ss.12-25, 2026 (SCI-Expanded, Scopus)

8. The role of complement C3 deposition in ANCA-associated glomerulonephritis: a registry-based study of clinical, histopathological, and prognostic insights

UZUN S., GÖK OĞUZ E., YILDIZ A., DERİCİ Ü., Cankaya E., ŞAHİN G., et al.

BMC Nephrology , cilt.26, sa.1, 2025 (SCI-Expanded, Scopus)

9. The effect of HbA1C variability on the development and progression of diabetic nephropathy

Coskun A., ÇALIM A., SAYGILI E. S., SAKACI T., YENER ÖZTÜRK F., Koc Y., et al.

Frontiers in Clinical Diabetes and Healthcare , cilt.6, 2025 (ESCI, Scopus)

10. Peripheral Blood Lymphocyte Subgroups in Patients Undergoing Hemodialysis with Medium Cutoff Membranes and High-Flux Membranes: The SHE Continuation Study

Hasbal N. B., Sevinc M., YILMAZ V., YILMAZ A., YÜCEER KORKMAZ H., BAŞTÜRK T., et al.

Blood Purification , cilt.53, sa.11-12, ss.937-946, 2024 (SCI-Expanded, Scopus)

11. Observational study of immunosuppressive treatment patterns and outcomes in primary membranous nephropathy: a multicenter retrospective analysis

UÇAR A. S., Mirioğlu Ş., Hocaoğlu R. H., Turgutalp K., Güllülü Boz S. E., EREN N., et al.

BMC Nephrology , cilt.25, sa.1, 2024 (SCI-Expanded, Scopus)

12. Prognostic factors and validation of the histologic chronicity score for C3 glomerulopathy: a registry analysis

Mirioglu S., CEBECİ E., Yazici H., DERİCİ Ü., ŞAHİN G., ÇOBAN G., et al.

Clinical Kidney Journal , cilt.17, sa.8, 2024 (SCI-Expanded, Scopus)

13. Could mesangial C3 deposition be an independent prognostic marker in immunoglobulin A nephropathy?

Cetinkaya H., GÜRSU M., Yazici H., CEBECİ E., EREN N., ALTIPARMAK M. R., et al.

Journal of Nephrology , cilt.37, sa.4, ss.923-932, 2024 (SCI-Expanded, Scopus)

14. Post-COVID-19 Outcomes of Patients with Primary Glomerular Diseases: A Nationwide Controlled Study

Öztürk S., KARADAĞ S., ARICI M., Türkmen A., Turgutalp K., Aktaş N., et al.

Turkish Journal of Nephrology , cilt.33, sa.2, ss.179, 2024 (ESCI, Scopus, TRDizin)

15. Immunosuppressive treatment results in patients with primary IgA nephropathy in Turkiye; the data from TSN-GOLD working group

ORUÇ A., ŞUMNU A., Turkmen A., BAŞTÜRK T., CEBECİ E., Turgutalp K., et al.

Renal Failure , cilt.46, sa.1, 2024 (SCI-Expanded, Scopus)

16. Determinants of non-diabetic kidney diseases in type 2 diabetic patients: Twenty years of single center experience

SAKACI T., AHBAP E., BAŞTÜRK T., Ortaboz M., Ozagari A. A., Mazı E. E., et al.

Clinical Nephrology , cilt.101, sa.5, ss.207-221, 2024 (SCI-Expanded, Scopus)

17. Peritoneal dialysis related non-infectious complications: A single-center experience over 20 years

AHBAP E., Mazi E. E., BAŞTÜRK T., SAKACI T., Aykent M. B., ÜNSAL A.

Clinical Nephrology , cilt.100, sa.1, ss.19-27, 2023 (SCI-Expanded, Scopus)

18. Post-COVID-19 outcomes of non-dialysis dependent chronic kidney disease patients: a national, multicenter, controlled study

KARADAĞ S., Ozturk S., ARICI M., GÖRGÜLÜ N., Akcali E., Pembegul I., et al.

International Urology and Nephrology , cilt.55, sa.2, ss.399-408, 2023 (SCI-Expanded, Scopus)

19. The relationship between glomerular IgG staining and poor prognostic findings in patients with IgA nephropathy: the data from TSN-GOLD working group

Turgutalp K., CEBECİ E., Turkmen A., DERİCİ Ü., SEYAHİ N., EREN N., et al.

BMC Nephrology , cilt.22, sa.1, 2021 (SCI-Expanded, Scopus)

20. Characteristics and outcomes of hospitalised older patients with chronic kidney disease and COVID-19: A multicenter nationwide controlled study

Ozturk S., Turgutalp K., ARICI M., GÖK M., Islam M., ALTIPARMAK M. R., et al.

International Journal of Clinical Practice , cilt.75, sa.9, 2021 (SCI-Expanded, Scopus)

21. Characteristics of primary glomerular diseases patients with hematuria in Turkey: the data from TSN-GOLD Working Group

ŞUMNU A., Turkmen K., CEBECİ E., Turkmen A., EREN N., SEYAHİ N., et al.

International Urology and Nephrology , cilt.53, sa.5, ss.945-954, 2021 (SCI-Expanded, Scopus)

22. Clinical significance of glomerular C3 deposition in primary membranous nephropathy

OTO Ö. A., Demir E., Mirioglu S., DİRİM A. B., ÖZLÜK M. Y., CEBECİ E., et al.

Journal of Nephrology , cilt.34, sa.2, ss.581-587, 2021 (SCI-Expanded, Scopus)

23. Demographic, clinical and laboratory characteristics of rapidly progressive glomerulonephritis in Turkey: Turkish Society of Nephrology-Glomerular Diseases (TSN-GOLD) Working Group

AYDIN Z., Turkmen K., DEDE F., Yasar E., Ozturk S., GÖKTUĞ M. R., et al.

Clinical and Experimental Nephrology , cilt.25, sa.2, ss.173-183, 2021 (SCI-Expanded, Scopus)

24. Comparison of lung ultrasound and other volumetric methods in peritoneal dialysis patients

Sevinc M., Hasbal N. B., BAŞTÜRK T., Ozcafer P. N., Kocas B. B., Kilickesmez K., et al.

Medicine (United States) , cilt.100, sa.3, 2021 (SCI-Expanded, Scopus)

25. Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: A nationwide analysis from Turkey

ÖZTÜRK S., Turgutalp K., ARICI M., Odabas A. R., ALTIPARMAK M. R., AYDIN Z., et al.

Nephrology Dialysis Transplantation , cilt.35, sa.12, ss.2083-2095, 2021 (SCI-Expanded, Scopus)

26. Frequency of depressive symptoms in Syrian refugees and Turkish maintenance hemodialysis patients during COVID-19 pandemic

Sevinc M., Hasbal N. B., SAKACI T., BAŞTÜRK T., AHBAP E., Ortaboz M., et al.

PLoS ONE , cilt.16, sa.1 January, 2021 (SCI-Expanded, Scopus)

27. The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis

Xie J., Liu L., Mladkova N., Li Y., Ren H., Wang W., et al.

Nature Communications , cilt.11, sa.1, 2020 (SCI-Expanded, Scopus)

28. Comparison of Circulating Levels of Uremic Toxins in Hemodialysis Patients Treated with Medium Cut-Off Membranes and High-Flux Membranes: Theranova in Sisli Hamidiye Etfal (THE SHE) Randomized Control Study

Sevinc M., Hasbal N. B., YILMAZ V., BAŞTÜRK T., AHBAP E., SAKACI T., et al.

Blood Purification , cilt.49, sa.6, ss.733-742, 2020 (SCI-Expanded, Scopus)

29. A familial Mediterranean fever patient with double homozygous mutations treated with anakinra after kidney transplantation Un paciente con poliserositis familiar recurrente con mutaciones homocigóticas dobles tratado con anakinra tras un trasplante renal

Hasbal N. B., Koc Y., Sevinc M., ÜNSAL A., BAŞTÜRK T.

Nefrologia , cilt.40, sa.5, ss.563-564, 2020 (Scopus)

30. Amyloid a amyloidosis after renal transplantation: An important cause of mortality

Sarihan I., Caliskan Y., Mirioglu S., ÖZLÜK M. Y., Senates B., SEYAHİ N., et al.

Transplantation , cilt.104, sa.8, ss.1703-1711, 2020 (SCI-Expanded, Scopus)

31. Prevalence and characteristics of atrial fibrillation in Turkish patients undergoing hemodialysis

Hasbal N. B., Koç Y., SAKACI T., Sevinç M., Uçar Z. A., ŞAHUTOĞLU T., et al.

Turkish Journal of Nephrology , cilt.29, sa.3, ss.215-220, 2020 (ESCI, Scopus, TRDizin)

32. Pentraxin-2 is associated with renal fibrosis in patients undergoing renal biopsy

BAŞTÜRK T., Ojalvo D., Mazi E. E., Hasbal N. B., Ozagari A. A., AHBAP E., et al.

Clinics , cilt.75, ss.1-5, 2020 (SCI-Expanded, Scopus)

33. Unexpectedly High Prevalence of Low Alpha-Galactosidase A Enzyme Activity in Patients with Focal Segmental Glomerulosclerosis

Hasbal N. B., Caglayan F. B., SAKACI T., AHBAP E., Koc Y., Sevinc M., et al.

Clinics , cilt.75, 2020 (SCI-Expanded, Scopus)

34. Kidney Transplantation Outcomes in Temporarily Protected Syrian Patients With End-Stage Renal Failure in Turkey

Sevinc M., Hasbal N. B., ÖZÇELİK G., Akinci N., BAŞTÜRK T., Koc Y., et al.

Transplantation Proceedings , cilt.51, sa.7, ss.2279-2282, 2019 (SCI-Expanded, Scopus)

35. Fabry Disease Prevalence in Renal Replacement Therapy in Turkey

Yalln S. F., EREN N., Sinangil A., YILMAZ V. T., Tatar E., Ucar A. R., et al.

Nephron , cilt.142, sa.1, ss.26-33, 2019 (SCI-Expanded, Scopus)

36. The impact of peritonitis on clinical outcomes of PD patients: A single center experience

Uçar Z. A., Koç Y., BAŞTÜRK T., Çağlayan F. B., SAKACI T., AHBAP E., et al.

Turkish Journal of Nephrology , cilt.28, sa.1, ss.54-61, 2019 (Scopus, TRDizin)

37. First Case of Right Malrotated Kidney Transplantation

DOKUCU A. İ., Yesildal C., KİREÇÇİ S. L., Ilgi M., BAŞTÜRK T., ERTÜRK Ş. M.

Transplantation Proceedings , cilt.50, sa.10, ss.3923-3924, 2018 (SCI-Expanded, Scopus)

38. Encapsulated peritoneal sclerosis: A single center, retrospective analysis of clinical manifestations, risk factors and prognosis

Koc Y., BAŞTÜRK T., SAKACI T., Caglayan F. B., Hasbal N. B., AHBAP E., et al.

Minerva Urologica e Nefrologica , cilt.70, sa.4, ss.429-436, 2018 (SCI-Expanded, Scopus)

39. Frequency of polyneuropathy in patients on long term peritoneal dialysis treatment

BAŞTÜRK T., Koc Y., ÖZDEMİR A., Yilmaz F., Hasbal N. B., SAKACI T., et al.

Journal of Clinical and Diagnostic Research , cilt.11, sa.6, 2017 (Scopus)

40. Serum VEGF-C levels as a candidate biomarker of hypervolemia in chronic kidney disease

ŞAHUTOĞLU T., SAKACI T., Hasbal N. B., AHBAP E., KARA E., Sumerkan M. C., et al.

Medicine (United States) , cilt.96, sa.18, 2017 (SCI-Expanded, Scopus)

41. The incidence of new onset diabetes after transplantation and related factors: Single center experience Incidencia de diabetes postrasplante de nueva aparición y factores relacionados: experiencia de un único centro

Sinangil A., Celik V., Barlas S., Koc Y., BAŞTÜRK T., SAKACI T., et al.

Nefrologia , cilt.37, sa.2, ss.181-188, 2017 (Scopus)

42. Air embolism following removal of hemodialysis catheter

ŞAHUTOĞLU T., SAKACI T., Hasbal N. B., KARA E., AHBAP E., Sevinc M., et al.

Hemodialysis International , cilt.21, sa.1, ss.29-34, 2017 (SCI-Expanded, Scopus)

43. Leukocytoclastic vasculitis associated with a new anticoagulant: Rivaroxaban Yeni bir antikoagülanla ilişkili lökositoklastik vaskülit: Rivaroksaban

Hasbal N. B., BAŞTÜRK T., Koç Y., ŞAHUTOĞLU T., Çağlayan F. B., ÜNSAL A.

Turkish Journal of Hematology , cilt.34, sa.1, ss.116-117, 2017 (SCI-Expanded, Scopus, TRDizin)

44. Prognostic significance of NGAL in early stage chronic kidney disease

BAŞTÜRK T., Sari O., Koc Y., Eren N., Isleem M., KARA E., et al.

Minerva Urologica e Nefrologica , cilt.69, sa.3, ss.307-312, 2017 (SCI-Expanded, Scopus)

45. Test of the recommended dialysis dose on one-year mortality of nondiabetic maintenance hemodialysis patients; observations from a single dialysis unit

ŞAHUTOĞLU T., KARA E., AHBAP E., SAKACI T., Koc Y., BAŞTÜRK T., et al.

Renal Failure , cilt.38, sa.8, ss.1174-1179, 2016 (SCI-Expanded, Scopus)

46. Serum uric acid levels and inflammatory markers with respect to dipping status: A retrospective analysis of hypertensive patients with or without chronic kidney disease

AHBAP E., SAKACI T., KARA E., ŞAHUTOĞLU T., Koc Y., BAŞTÜRK T., et al.

Clinical and Experimental Hypertension , cilt.38, sa.6, ss.555-563, 2016 (SCI-Expanded, Scopus)

47. Can eculizumab be discontinued in aHUS?: Case report and review of the literature

ŞAHUTOĞLU T., BAŞTÜRK T., SAKACI T., Koc Y., AHBAP E., Sevinc M., et al.

Medicine (United States) , cilt.95, sa.31, 2016 (SCI-Expanded, Scopus)

48. Is peritoneal dialysis a therapeutic option for polycystic kidney disease? 15 years’ experience in a single center

Koc Y., BAŞTÜRK T., SAKACI T., Atan Ucar Z., AHBAP E., Sevinc M., et al.

Nephrologie et Therapeutique , cilt.12, sa.4, ss.215-220, 2016 (SCI-Expanded, Scopus)

49. Persistent left superior vena cava: Two case reports and a review from nephrologists’ perspective

ŞAHUTOĞLU T., SAKACI T., KARA E., AHBAP E., BAŞTÜRK T., Koc Y., et al.

Hemodialysis International , cilt.20, sa.3, ss.369-377, 2016 (SCI-Expanded, Scopus)

50. Posttransplant Urinary Tract Infection Rates and Graft Outcome in Kidney Transplantation for End-Stage Renal Disease Due to Reflux Nephropathy Versus Chronic Glomerulonephritis

KARA E., SAKACI T., AHBAP E., ŞAHUTOĞLU T., Koc Y., BAŞTÜRK T., et al.

Transplantation Proceedings , cilt.48, sa.6, ss.2065-2071, 2016 (SCI-Expanded, Scopus)

51. Does body mass index affect survival and technique failure in patients undergoing peritoneal dialysis?

SAKACI T., AHBAP E., BAŞTÜRK T., Koc Y., KARA E., Sevinc M., et al.

Minerva Urologica e Nefrologica , cilt.68, sa.3, ss.302-310, 2016 (SCI-Expanded, Scopus)

52. The relationship between serum albumin levels and 24-h ambulatory blood pressure monitoring recordings in non-diabetic essential hypertensive patients

AHBAP E., SAKACI T., KARA E., ŞAHUTOĞLU T., Koc Y., BAŞTÜRK T., et al.

Clinics , cilt.71, sa.5, ss.257-263, 2016 (SCI-Expanded, Scopus)

53. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in evaluation of inflammation in end-stage renal disease

AHBAP E., SAKACI T., KARA E., ŞAHUTOĞLU T., Koc Y., BAŞTÜRK T., et al.

Clinical Nephrology , cilt.85, sa.4, ss.199-208, 2016 (SCI-Expanded, Scopus)

54. New-onset diabetes after kidney transplantation and pretransplant hypomagnesemia

Sinangil A., Celik V., Barlas S., SAKACI T., Koc Y., BAŞTÜRK T., et al.

Progress in Transplantation , cilt.26, sa.1, ss.55-61, 2016 (SCI-Expanded, Scopus)

55. Comparison of long-term complications in patients on haemodialysis and peritoneal dialysis longer than 10 years

ÖZDEMİR A., BAŞTÜRK T., Koc Y., Yilmaz F., Caglayan F. B., SAKACI T., et al.

Journal of Clinical and Diagnostic Research , cilt.10, sa.2, 2016 (Scopus)

56. The predictive value of malnutrition - inflammation score on 1-year mortality in Turkish maintenance hemodialysis patients

KARA E., ŞAHUTOĞLU T., AHBAP E., SAKACI T., Koc Y., BAŞTÜRK T., et al.

Clinical Nephrology , cilt.86, sa.8, ss.94-99, 2016 (SCI-Expanded, Scopus)

57. Familial mediterranean fever is associated with abnormal ventricular repolarization indices La fiebre mediterránea familiar se asocia a anomalías en la repolarizacıón ventricular

AHBAP E., SAKACI T., KARA E., ŞAHUTOĞLU T., Ozturk S., BAŞTÜRK T., et al.

Revista Medica de Chile , cilt.143, sa.12, ss.1560-1568, 2015 (SCI-Expanded, Scopus)

58. Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: A case report

Sevinc M., BAŞTÜRK T., ŞAHUTOĞLU T., SAKACI T., Koc Y., AHBAP E., et al.

Journal of Medical Case Reports , cilt.9, sa.1, 2015 (Scopus)

59. Clinical outcomes and mortality in elderly peritoneal dialysis patients

SAKACI T., AHBAP E., Koc Y., BAŞTÜRK T., Ucar Z. A., Sınangıl A., et al.

Clinics , cilt.70, sa.5, ss.363-368, 2015 (SCI-Expanded, Scopus)

60. Renal damage frequency in patients with solitary kidney and factors that affect progression

BAŞTÜRK T., Koc Y., Ucar Z., SAKACI T., AHBAP E., KARA E., et al.

International Journal of Nephrology , cilt.2015, 2015 (Scopus)

61. Elevated serum leptin levels are associated with good nutritional status in non-obese chronic hemodialysis patients

KARA E., AHBAP E., ŞAHUTOĞLU T., SAKACI T., BAŞTÜRK T., Koc Y., et al.

Clinical Nephrology , cilt.83, sa.3, ss.147-153, 2015 (SCI-Expanded, Scopus)

62. Relationship between relative interdialytic weight gain and serum leptin levels, nutrition, and inflammation in chronic hemodialysis patients

AHBAP E., SAKACI T., KARA E., ŞAHUTOĞLU T., Koc Y., BAŞTÜRK T., et al.

Clinical Nephrology , cilt.83, sa.3, ss.154-160, 2015 (SCI-Expanded, Scopus)

63. Effect of initial PET status on clinical course in peritoneal dialysis patients

SAKACI T., Koc Y., BAŞTÜRK T., Sevinc M., AHBAP E., Sinangil A., et al.

BANTAO Journal , cilt.13, sa.1, ss.14-19, 2015 (Scopus)

64. Evaluation of the serum cystatin C values in prediction of indications for hemodialysis in patients with chronic renal failure

ŞİT D., BAŞTÜRK T., Yildirim S., Karagoz F., Bozkurt N., Gunes A.

International Urology and Nephrology , cilt.46, sa.1, ss.57-62, 2014 (SCI-Expanded, Scopus)

65. Outcome of 121 patients with renal amyloid A amyloidosis

AHBAP E., KARA E., ŞAHUTOĞLU T., BAŞTÜRK T., Koc Y., SAKACI T., et al.

Journal of Research in Medical Sciences , cilt.19, sa.7, ss.644-649, 2014 (SCI-Expanded, Scopus)

66. Clinical outcomes and mortality in peritoneal dialysis patients: A 10-year retrospective analysis in a single center

ÜNSAL A., Koc Y., BAŞTÜRK T., SAKACI T., AHBAP E., Sinangil A., et al.

Clinical Nephrology , cilt.80, sa.4, ss.270-279, 2013 (SCI-Expanded, Scopus)

67. Effects of infectious complications on patients' survival in peritoneal dialysis

Sinangil A., Koc Y., ÜNSAL A., BAŞTÜRK T., SAKACI T., AHBAP E., et al.

European Review for Medical and Pharmacological Sciences , cilt.17, sa.8, ss.1064-1072, 2013 (SCI-Expanded, Scopus)

68. Tuberculosis in dialysis patients: A nine-year retrospective analysis

ÜNSAL A., AHBAP E., BAŞTÜRK T., Koc Y., SAKACI T., Arar A. S., et al.

Journal of Infection in Developing Countries , cilt.7, sa.3, ss.208-213, 2013 (SCI-Expanded, Scopus)

69. A rare drop-out cause of peritoneal dialysis: Persistent hiccups Periton Diyalizinin Ender Görülen Sonlandirilma Nedeni: Inatçi Hiçkirik

ÜNSAL A., Koç Y., ÖZDEMİR A., BAŞTÜRK T., Sevinç M., SAKACI T., et al.

Turkish Nephrology, Dialysis and Transplantation Journal , cilt.22, sa.1, ss.120-122, 2013 (Scopus, TRDizin)

70. Renal sarcoidosis with normal serum vitamin D and refractory hypercalcemia

ÜNSAL A., BAŞTÜRK T., Koc Y., SAKACI T., AHBAP E., Ozagarı A., et al.

International Urology and Nephrology , cilt.45, sa.6, ss.1779-1783, 2013 (SCI-Expanded, Scopus)

71. Effects of AA amyloidosis on survival in peritoneal dialysis

Koc Y., BAŞTÜRK T., ÜNSAL A., SAKACI T., AHBAP E., Sinangil A., et al.

Kidney and Blood Pressure Research , cilt.36, sa.1, ss.182-190, 2012 (SCI-Expanded, Scopus)

72. Factors Associated with above and under 5-Year Survival in Peritoneal Dialysis Patients

ÜNSAL A., BAŞTÜRK T., Koc Y., Sinangil A., AHBAP E., SAKACI T., et al.

Renal Failure , cilt.34, sa.9, ss.1129-1134, 2012 (SCI-Expanded, Scopus)

73. Is there impact of mortality prior hemodialysis therapy in peritoneal dialysis patients?

Koc Y., ÜNSAL A., BAŞTÜRK T., SAKACI T., Ahbap-Dal E., Sinangil-Arar A., et al.

Nefrologia , cilt.32, sa.3, ss.335-342, 2012 (SCI-Expanded, Scopus)

74. Relationship of fibroblast growth factor 23 with left ventricle mass index and coronary calcificaton in chronic renal disease

ÜNSAL A., Budak S. K., Koc Y., BAŞTÜRK T., SAKACI T., AHBAP E., et al.

Kidney and Blood Pressure Research , cilt.36, sa.1, ss.55-64, 2012 (SCI-Expanded, Scopus)

75. The effects of angiotensin-converting enzyme inhibitors on peritoneal protein loss and solute transport in peritoneal dialysis patients

BAŞTÜRK T., ÜNSAL A., Koc Y., Nezaket E., AHBAP E., SAKACI T., et al.

Clinics , cilt.67, sa.8, ss.877-883, 2012 (Scopus)

76. Evaluation of resistive index by color Doppler imaging of orbital arteries in type II diabetes mellitus patients with microalbuminuria

BAŞTÜRK T., Albayrak R., Ulas T., Akcay M., ÜNSAL A., Toksoy M., et al.

Renal Failure , cilt.34, sa.6, ss.708-712, 2012 (SCI-Expanded, Scopus)

77. Risk factors for progression of renal disease in patient with diabetic nephropathy

ÜNSAL A., Koc Y., BAŞTÜRK T., Akgun A., SAKACI T., AHBAP E.

European Review for Medical and Pharmacological Sciences , cilt.16, sa.7, ss.878-883, 2012 (SCI-Expanded, Scopus)

78. Correlation between the resistive index values of renal and orbital arteries

BAŞTÜRK T., Akcay M., Albayrak R., ÜNSAL A., Ulas T., Koc Y.

Kidney and Blood Pressure Research , cilt.35, sa.5, ss.332-339, 2012 (SCI-Expanded, Scopus)

79. What is the frequency of carbohydrate metabolism disorder in CKD?

BAŞTÜRK T., ÜNSAL A.

Journal of Renal Care , cilt.38, sa.1, ss.15-21, 2012 (Scopus)

80. Effects of rosiglitazone treatment on insulin resistance and TNF-alpha levels in patients with chronic kidney disease: a prospective study.

BAŞTÜRK T., ÜNSAL A., Ulas T., Koc Y., SAKACI T., AHBAP E., et al.

European review for medical and pharmacological sciences , cilt.16, sa.11, ss.1519-1524, 2012 (SCI-Expanded, Scopus)

81. Effects of human umbilical cord stem cells and granulocyte colony-stimulating factor (G-CSF) on carbon tetrachloride-induced nephrotoxicity

Koc Y., Sokmen M., ÜNSAL A., Cigerli S., Ozagari A., BAŞTÜRK T., et al.

Nephro-Urology Monthly , cilt.4, sa.3, ss.545-550, 2012 (Scopus)

82. Fungal peritonitis in peritoneal dialysis: a 10 year retrospective analysis in a single center.

BAŞTÜRK T., Koc Y., ÜNSAL A., AHBAP E., SAKACI T., Yildiz I., et al.

European review for medical and pharmacological sciences , cilt.16, sa.12, ss.1696-1700, 2012 (SCI-Expanded, Scopus)

83. Epidemic acute methanol intoxication as a result of illicit alcohol ingestion

ÜNSAL A., BAŞTÜRK T., Sakac T., AHBAP E., Koç Y., YILMAZ M.

Nephro-Urology Monthly , cilt.4, sa.1, ss.366-371, 2012 (Scopus)

84. Relationship between serum tumor necrosis factor-alpha levels and insulin resistance in patients with chronic renal failure Kronik böbrek yetersizliǧi olan hastalarda serum tümör nekroz faktörü-alfa düzeyleri ile insülin direnci ilişkisi

Ulaş T., BAŞTÜRK T., SAKACI T., ÜNSAL A., Borlu F.

Turkiye Klinikleri Journal of Medical Sciences , cilt.32, sa.1, ss.157-161, 2012 (Scopus)

85. Effect of cholecalciferol on parathyroid hormone and vitamin D levels in chronic kidney disease

BAŞTÜRK T., ÜNSAL A., Ulas T.

Minerva Urologica e Nefrologica , cilt.63, sa.4, ss.287-292, 2011 (Scopus)

86. Effect of Olmesartan on serum cystatin C levels in the patients with essential hypertension

Koc Y., Mazi E., SAKACI T., BAŞTÜRK T., Batuhan Damar A., AHBAP E., et al.

European Review for Medical and Pharmacological Sciences , cilt.15, sa.12, ss.1389-1394, 2011 (SCI-Expanded, Scopus)

87. Magnesium changes during hemodialysis alter the QTc interval and QTc dispersion

BAŞTÜRK T., Abdulkadir U., Yener K., Tamer S., Murvet Y., Elbis A.

Dialisis y Trasplante , cilt.32, sa.4, ss.142-146, 2011 (Scopus)

88. Is insulin resistance a risk factor for the progression of chronic kidney disease?

BAŞTÜRK T., ÜNSAL A.

Kidney and Blood Pressure Research , cilt.34, sa.2, ss.111-115, 2011 (SCI-Expanded, Scopus)

89. The effects of the recommended dose of creatine monohydrate on kidney function

BAŞTÜRK T., Aysim O., Abdulkadir U.

NDT Plus , cilt.4, sa.1, ss.23-24, 2011 (Scopus)

90. Tuberculosis in peritoneal dialysis patients in an endemic region.

Gursu M., Tayfur F., Besler M., Kaptanogullari O., Kucuk M., AYDIN Z., et al.

Advances in peritoneal dialysis. Conference on Peritoneal Dialysis , cilt.27, ss.48-52, 2011 (Scopus)

91. Membranoproliferative glomerulonephritis and a rare bleeding disorder: Factor X deficiency

BAŞTÜRK T., AHBAP E., Eroglu Kesim B., YILMAZ M., Koç Y., SAKACI T., et al.

International Urology and Nephrology , cilt.43, sa.4, ss.1237-1241, 2011 (SCI-Expanded, Scopus)

92. Crohn's disease and secondary amyloidosis: Early complication? A case report and review of the literature

BAŞTÜRK T., Ozagari A., Ozturk T., Kusaslan R., ÜNSAL A.

Journal of Renal Care , cilt.35, sa.3, ss.147-150, 2009 (Scopus)

93. Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination

BAŞTÜRK T., ALTUNTAŞ Y., Kurklu A., Aydin L., Eren N., ÜNSAL A.

Renal Failure , cilt.28, sa.2, ss.125-128, 2006 (SCI-Expanded, Scopus)

94. Rhabdomyolysis and severe haemolytic anaemia, hepatic dysfunction and intestinal osteopathy due to hypophosphataemia in a patient after Billroth II gastrectomy

ALTUNTAŞ Y., Innice M., BAŞTÜRK T., Seber S., Serin G., Ozturk B.

European Journal of Gastroenterology and Hepatology , cilt.14, sa.5, ss.555-557, 2002 (Scopus)

95. Urinary excretion of N-acetyl-beta-D-glucosaminidase in newly diagnosed essential hypertensive patients and its changes with effective antihypertensive therapy

Harmankaya Ö., Öztürk Y., BAŞTÜRK T., Öbek A.

International Urology and Nephrology , cilt.32, sa.4, ss.583-584, 2001 (Scopus)

96. Effect of acetylsalicyclic acid and dipyridamole in primary membranoproliferative glomerulonephritis type I

Harmankaya Ö., BAŞTÜRK T., Öztürk Y., Karabiber N., Öbek A.

International Urology and Nephrology , cilt.33, sa.3, ss.583-587, 2001 (Scopus)

Yayınlar & Eserler

Yayın

Yayın (WoS)

Yayın (Scopus)

H-İndeks (WoS)

Atıf (Scopus)

H-İndeks (Scopus)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Diğer Toplam)

Proje

Tez Danışmanlığı

Açık Erişim